Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial-Reference-Cited by-同舟云学术

Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial

Published:2022-12 Issue:12 Volume:9 Page:e878-e885
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Jabbour Elias,Short Nicholas J,Jain Nitin,Thompson Philip A,Kadia Tapan M,Ferrajoli Alessandra,Huang Xuelin,Yilmaz Musa,Alvarado Yesid,Patel Keyur P,Garcia-Manero Guillermo,Macaron Walid,Garris Rebecca,Konopleva Marina,Ravandi Farhad,Kantarjian Hagop

Publisher

Elsevier BV

Subject

Hematology

Reference21 articles.

1. Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigms;Short;Leukemia,2021

2. Acute lymphoblastic leukemia: a population-based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980–2017;Sasaki;Am J Hematol,2021

3. Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia;Thomas;J Clin Oncol,2010

4. Rituximab in B-lineage adult acute lymphoblastic leukemia;Maury;N Engl J Med,2016

5. Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial;Ribrag;Lancet,2016

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial;Journal of Hematology & Oncology;2024-09-02

2. SOHO State of the Art Updates and Next Questions | Novel Agents and the Diminishing Role of Allogeneic Stem Cell Transplant in B-Acute Lymphoblastic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Immunotherapy in first line treatment of adult acute lymphoblastic leukemia;Current Opinion in Oncology;2024-08-13

4. Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directions;Cancer;2024-08-02

5. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults;New England Journal of Medicine;2024-07-25